Spasticity and Treatment Satisfaction Among Stroke Survivors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-20

Study Completion Date

2020-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate, through ethnography, changes in symptom burden and disability and their effects/interference on patient functioning, ability to perform activities of daily living (ADL) and quality of life (QoL) throughout the duration of one BoNT-A treatment cycle.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adult Subjects Suffering From Lower Limb Spasticity Following Stroke

NCT01444794

Spasticity

COMPLETED

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

NCT02390206

Spasticity

COMPLETED

Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

NCT05224349

Post-Stroke Chronic Upper Limb Spasticity

COMPLETED

To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke

NCT01020500

Muscle Spasticity

COMPLETED

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke

NCT01392300

Post-stroke Spasticity of the Upper Limb

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spasticity as Sequela of Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnostic of post-stroke spasticity more than three months prior to inclusion
* At least 6 months on treatment (or two treatment cycles) with BoNT-A injections for spasticity according to the decision of the physician
* Previous BoNT-A injection cycles did not last for more than 16 weeks
* Ambulatory (use of walking aids is acceptable)

Exclusion Criteria

* Neurological disorder other than stroke
* Spasticity-specific treatment changes within 3 months prior to inclusion
* Patients who had undergone neurolysis or surgery to the affected limb within 6 months
* Concurrent participation in a clinical trial for the treatment of spasticity

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No